Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed Plus Cisplatin in Advanced Gastric Carcinoma
NCT00320515Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2004
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pemetrexed in gastric adenocarcinoma, sponsored by Eli Lilly and Company. Started Mar 2004; status: completed.
02
Drugs
pemetrexed
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00320515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320515.